Skip to content

13G filed by Bain Capital Life Sciences Opportunities IV, L.P.

Bain Capital Life Sciences Opportunities IV, L.P. reported 14,825,625 ADCT shares, 9.99% of the class, as of 2026-10-22, in a 13G accepted by EDGAR 2026-10-29 21:45:34 UTC.

Accession
0001193125-26-438199
Filed
2026-10-29
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Stake

Shares
14,825,625
Percent of class
9.99%
Event date
2026-10-22

How the shares relate across the reporting persons: one reporting person counts. The page shows the largest row.

Read for the filer group Bain Capital Life Sciences Investors, LLC.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
Bain Capital Life Sciences Opportunities IV, L.P.PN014,825,625014,825,62514,825,6259.99%